Sinobiopharma secures rights to seven key patents

NewsGuard 100/100 Score

Sinobiopharma Inc. has announced that it has secured rights to seven key patents from Company CEO Dr. Lequn Huang and the patents' co-holders.

The patents that will significantly enhance Sinobiopharma's ability to execute on its mission of bringing safe, low-cost, high-efficacy biopharmaceuticals to market.

The patents are for the following:

1. Synthesis of amantadine hydrochloride
2. Method for preparation of 17-acylsinomenine derivatives
3. Preparation of 17-sulfonylsinomenine
4. Preparation of N-substituted sinomenine
5. Method for preparation of Sinomenine compound having dextro-rotary C
ring-deficient morphinan skeleton
6. Synthesis of Eplerenone from 11 -hydroxycanrenone
7. Method for resolving tetrahydroisoquinoline racemate

Sinobiopharma will be applying these patents as well as using its own innovative applications of them in new drug development.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.